<?xml version="1.0" encoding="UTF-8"?>
<ref id="B89-ijms-22-01591">
 <label>89.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ya</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Serum miR-129 functions as a biomarker for colorectal cancer by targeting estrogen receptor (ER) beta</article-title>
  <source>Pharmazie</source>
  <year>2017</year>
  <volume>72</volume>
  <fpage>107</fpage>
  <lpage>112</lpage>
  <pub-id pub-id-type="doi">10.1691/ph.2017.6718</pub-id>
  <pub-id pub-id-type="pmid">29441863</pub-id>
 </element-citation>
</ref>
